Chronic myeloid leukemia stem cells: targeting therapeutic implications
Abstract Chronic myeloid leukemia (CML) is a clonal myeloproliferative neoplasm driven by BCR-ABL1 oncoprotein, which plays a pivotal role in CML pathology, diagnosis, and treatment as confirmed by the success of tyrosine kinase inhibitor (TKI) therapy. Despite advances in the development of more po...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2021-12-01
|
| シリーズ: | Stem Cell Research & Therapy |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s13287-021-02659-1 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|